questionsmedicales.fr
Maladies du système nerveux
Maladies neurodégénératives
Maladies neurodégénératives : Questions médicales fréquentes
Diagnostic
5
Maladie d'Alzheimer
Évaluation cognitive
Sclérose en plaques
Imagerie par résonance magnétique
Maladie de Parkinson
Tremblements
Démence frontotemporale
Imagerie cérébrale
Maladie de Huntington
Tests génétiques
Symptômes
5
Maladie d'Alzheimer
Symptômes cognitifs
Sclérose en plaques
Fatigue
Maladie de Parkinson
Bradykinésie
Démence frontotemporale
Changements de personnalité
Maladie de Huntington
Troubles cognitifs
Prévention
5
Maladie d'Alzheimer
Prévention
Sclérose en plaques
Mode de vie sain
Maladie de Parkinson
Antioxydants
Démence frontotemporale
Prévention
Maladie de Huntington
Suivi médical
Traitements
5
Maladie d'Alzheimer
Inhibiteurs de la cholinestérase
Sclérose en plaques
Corticostéroïdes
Maladie de Parkinson
Lévodopa
Démence frontotemporale
Thérapies
Maladie de Huntington
Gestion des symptômes
Complications
5
Maladie d'Alzheimer
Complications
Sclérose en plaques
Infections urinaires
Maladie de Parkinson
Troubles de la déglutition
Démence frontotemporale
Comportements agressifs
Maladie de Huntington
Troubles psychiatriques
Facteurs de risque
5
Maladie d'Alzheimer
Facteurs de risque
Sclérose en plaques
Antécédents familiaux
Maladie de Parkinson
Exposition à des toxines
Démence frontotemporale
Facteurs génétiques
Maladie de Huntington
Hérédité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies neurodégénératives : Questions médicales les plus fréquentes",
"headline": "Maladies neurodégénératives : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies neurodégénératives : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-20",
"dateModified": "2026-03-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies neurodégénératives"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D009422",
"about": {
"@type": "MedicalCondition",
"name": "Maladies du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Syndromes neurologiques paranéoplasiques",
"alternateName": "Paraneoplastic Syndromes, Nervous System",
"url": "https://questionsmedicales.fr/mesh/D020361",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes neurologiques paranéoplasiques",
"code": {
"@type": "MedicalCode",
"code": "D020361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.781"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dégénérescence cérébelleuse paranéoplasique",
"alternateName": "Paraneoplastic Cerebellar Degeneration",
"url": "https://questionsmedicales.fr/mesh/D020362",
"about": {
"@type": "MedicalCondition",
"name": "Dégénérescence cérébelleuse paranéoplasique",
"code": {
"@type": "MedicalCode",
"code": "D020362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.781.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladies à prions",
"alternateName": "Prion Diseases",
"url": "https://questionsmedicales.fr/mesh/D017096",
"about": {
"@type": "MedicalCondition",
"name": "Maladies à prions",
"code": {
"@type": "MedicalCode",
"code": "D017096",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.843"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Kuru",
"alternateName": "Kuru",
"url": "https://questionsmedicales.fr/mesh/D007729",
"about": {
"@type": "MedicalCondition",
"name": "Kuru",
"code": {
"@type": "MedicalCode",
"code": "D007729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.843.625"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Atrophie multisystématisée",
"alternateName": "Multiple System Atrophy",
"url": "https://questionsmedicales.fr/mesh/D019578",
"about": {
"@type": "MedicalCondition",
"name": "Atrophie multisystématisée",
"code": {
"@type": "MedicalCode",
"code": "D019578",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.928.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie de Parkinson",
"alternateName": "Parkinson Disease",
"url": "https://questionsmedicales.fr/mesh/D010300",
"about": {
"@type": "MedicalCondition",
"name": "Maladie de Parkinson",
"code": {
"@type": "MedicalCode",
"code": "D010300",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.928.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tauopathies",
"alternateName": "Tauopathies",
"url": "https://questionsmedicales.fr/mesh/D024801",
"about": {
"@type": "MedicalCondition",
"name": "Tauopathies",
"code": {
"@type": "MedicalCode",
"code": "D024801",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.945"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dégénérescence corticobasale",
"alternateName": "Corticobasal Degeneration",
"url": "https://questionsmedicales.fr/mesh/D000088282",
"about": {
"@type": "MedicalCondition",
"name": "Dégénérescence corticobasale",
"code": {
"@type": "MedicalCode",
"code": "D000088282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.574.945.312"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladies neurodégénératives",
"alternateName": "Neurodegenerative Diseases",
"code": {
"@type": "MedicalCode",
"code": "D019636",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fabio Coppedè",
"url": "https://questionsmedicales.fr/author/Fabio%20Copped%C3%A8",
"affiliation": {
"@type": "Organization",
"name": "Medical Genetics Laboratory, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy."
}
},
{
"@type": "Person",
"name": "Andrea Stoccoro",
"url": "https://questionsmedicales.fr/author/Andrea%20Stoccoro",
"affiliation": {
"@type": "Organization",
"name": "Medical Genetics Laboratory, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy."
}
},
{
"@type": "Person",
"name": "Vicky Turner",
"url": "https://questionsmedicales.fr/author/Vicky%20Turner",
"affiliation": {
"@type": "Organization",
"name": "Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK."
}
},
{
"@type": "Person",
"name": "Masud Husain",
"url": "https://questionsmedicales.fr/author/Masud%20Husain",
"affiliation": {
"@type": "Organization",
"name": "Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. masud.husain@ndcn.ox.ac.uk."
}
},
{
"@type": "Person",
"name": "Sumit Kinger",
"url": "https://questionsmedicales.fr/author/Sumit%20Kinger",
"affiliation": {
"@type": "Organization",
"name": "Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Lipids in Neurodegenerative Diseases.",
"datePublished": "2023-07-16",
"url": "https://questionsmedicales.fr/article/37511282",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411523"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retina Oculomics in Neurodegenerative Disease.",
"datePublished": "2023-10-19",
"url": "https://questionsmedicales.fr/article/37855949",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10439-023-03365-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inflammasome assembly in neurodegenerative diseases.",
"datePublished": "2023-08-24",
"url": "https://questionsmedicales.fr/article/37633753",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tins.2023.07.009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive Interventions for Neurodegenerative Disease.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37428401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11910-023-01283-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases.",
"datePublished": "2023-10-19",
"url": "https://questionsmedicales.fr/article/37895020",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms242015340"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies neurodégénératives",
"item": "https://questionsmedicales.fr/mesh/D019636"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies neurodégénératives - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies neurodégénératives",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies neurodégénératives",
"description": "Comment diagnostiquer la maladie d'Alzheimer ?\nQuels tests pour la sclérose en plaques ?\nQuels signes indiquent la maladie de Parkinson ?\nComment évaluer la démence frontotemporale ?\nQuels examens pour la maladie de Huntington ?",
"url": "https://questionsmedicales.fr/mesh/D019636#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies neurodégénératives",
"description": "Quels sont les symptômes de la maladie d'Alzheimer ?\nQuels symptômes de la sclérose en plaques ?\nQuels signes de la maladie de Parkinson ?\nQuels symptômes de la démence frontotemporale ?\nQuels symptômes de la maladie de Huntington ?",
"url": "https://questionsmedicales.fr/mesh/D019636#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies neurodégénératives",
"description": "Peut-on prévenir la maladie d'Alzheimer ?\nComment réduire le risque de sclérose en plaques ?\nY a-t-il des moyens de prévenir la maladie de Parkinson ?\nPeut-on prévenir la démence frontotemporale ?\nComment prévenir la maladie de Huntington ?",
"url": "https://questionsmedicales.fr/mesh/D019636#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies neurodégénératives",
"description": "Quels traitements pour la maladie d'Alzheimer ?\nComment traiter la sclérose en plaques ?\nQuels médicaments pour la maladie de Parkinson ?\nY a-t-il un traitement pour la démence frontotemporale ?\nComment gérer la maladie de Huntington ?",
"url": "https://questionsmedicales.fr/mesh/D019636#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies neurodégénératives",
"description": "Quelles complications de la maladie d'Alzheimer ?\nQuels risques avec la sclérose en plaques ?\nQuelles complications de la maladie de Parkinson ?\nQuels risques avec la démence frontotemporale ?\nQuelles complications de la maladie de Huntington ?",
"url": "https://questionsmedicales.fr/mesh/D019636#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies neurodégénératives",
"description": "Quels facteurs de risque pour la maladie d'Alzheimer ?\nQuels risques pour la sclérose en plaques ?\nQuels facteurs de risque pour la maladie de Parkinson ?\nQuels risques pour la démence frontotemporale ?\nQuels facteurs de risque pour la maladie de Huntington ?",
"url": "https://questionsmedicales.fr/mesh/D019636#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la maladie d'Alzheimer ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation cognitive, l'imagerie cérébrale et des tests neuropsychologiques."
}
},
{
"@type": "Question",
"name": "Quels tests pour la sclérose en plaques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM, les potentiels évoqués et l'analyse du liquide céphalorachidien sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent la maladie de Parkinson ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tremblements, la rigidité musculaire et les troubles de la marche sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment évaluer la démence frontotemporale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation clinique et les tests d'imagerie cérébrale aident à poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels examens pour la maladie de Huntington ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des évaluations neurologiques sont nécessaires pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la maladie d'Alzheimer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Perte de mémoire, confusion, difficultés de langage et changements de comportement."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la sclérose en plaques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles de la vision, engourdissements et problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "Quels signes de la maladie de Parkinson ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Tremblements, rigidité, bradykinésie et troubles de l'équilibre."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la démence frontotemporale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Changements de personnalité, troubles du langage et comportements inappropriés."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la maladie de Huntington ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mouvements involontaires, troubles cognitifs et changements d'humeur."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la maladie d'Alzheimer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que l'exercice, une alimentation saine et la stimulation cognitive peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de sclérose en plaques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac et maintenir un mode de vie sain peuvent diminuer le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des moyens de prévenir la maladie de Parkinson ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants et l'exercice régulier peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la démence frontotemporale ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de méthode prouvée pour prévenir cette maladie."
}
},
{
"@type": "Question",
"name": "Comment prévenir la maladie de Huntington ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention, mais un suivi médical peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la maladie d'Alzheimer ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs de la cholinestérase et la mémantine sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "Comment traiter la sclérose en plaques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les corticostéroïdes et les médicaments modificateurs de la maladie."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour la maladie de Parkinson ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La lévodopa et les agonistes de la dopamine sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un traitement pour la démence frontotemporale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique, mais des thérapies peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Comment gérer la maladie de Huntington ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements visent à soulager les symptômes, avec des médicaments pour les mouvements et l'humeur."
}
},
{
"@type": "Question",
"name": "Quelles complications de la maladie d'Alzheimer ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des problèmes de nutrition et des chutes."
}
},
{
"@type": "Question",
"name": "Quels risques avec la sclérose en plaques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des infections urinaires et des problèmes de mobilité."
}
},
{
"@type": "Question",
"name": "Quelles complications de la maladie de Parkinson ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de la déglutition et des chutes fréquentes."
}
},
{
"@type": "Question",
"name": "Quels risques avec la démence frontotemporale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des comportements agressifs et des troubles alimentaires."
}
},
{
"@type": "Question",
"name": "Quelles complications de la maladie de Huntington ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles psychiatriques et des problèmes de coordination."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la maladie d'Alzheimer ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les antécédents familiaux et les facteurs cardiovasculaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels risques pour la sclérose en plaques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sexe féminin, l'âge jeune et des antécédents familiaux sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la maladie de Parkinson ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, les antécédents familiaux et l'exposition à des toxines peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quels risques pour la démence frontotemporale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certains facteurs génétiques sont des risques connus."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la maladie de Huntington ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hérédité est le principal facteur de risque, avec un gène spécifique impliqué."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/03/2026
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
Medical Genetics Laboratory, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Medical Genetics Laboratory, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. masud.husain@ndcn.ox.ac.uk.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, Himachal Pradesh, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry, University of Delhi South Campus, Dhaula Kuan, New Delhi, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Simrol, Indore, Madhya Pradesh, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Department of Biotechnology, Indian Institute of Technology Hyderabad, Telangana, India.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Rajasthan, India. Electronic address: amit@iitj.ac.in.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Hasselt University, Biomedical Research Institute, BIOMED, 3500 Hasselt, Belgium. Electronic address: david.wilson@uhasselt.be.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
KU Leuven, University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), 3000 Leuven, Belgium; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, 3000 Leuven, Belgium.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK; UK Dementia Research Institute at UCL, London, UK; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China; UW Department of Medicine, School of Medicine and Public Health, Madison, WI, USA.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, MO, USA.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Hasselt University, Biomedical Research Institute, BIOMED, 3500 Hasselt, Belgium. Electronic address: ilse.dewachter@uhasselt.be.
Publications dans "Maladies neurodégénératives" :
1 publication dans cette catégorie
Affiliations :
Institute for Medical Science of Aging, Aichi Medical University.
Publications dans "Maladies neurodégénératives" :
Lipids are undoubtedly the major constituents of the cell membranes of all living organisms, and the most efficient source of energy [...]....
Ophthalmic biomarkers have long played a critical role in diagnosing and managing ocular diseases. Oculomics has emerged as a field that utilizes ocular imaging biomarkers to provide insights into sys...
Neurodegenerative disorders are characterized by the progressive dysfunction and death of selectively vulnerable neuronal populations, often associated with the accumulation of aggregated host protein...
To critically review recent research in the development of non-pharmacological interventions to improve cognitive functioning in individuals with Alzheimer's disease (AD) or Parkinson's disease (PD)....
Cognitive interventions can be grouped into three categories: cognitive stimulation (CS), cognitive training (CT), and cognitive rehabilitation (CR). CS confers temporary, nonspecific benefits and mig...
Neurodegenerative diseases affect millions of people worldwide. Neurodegenerative diseases result from progressive damage to nerve cells in the brain or peripheral nervous system connections that are ...
Diabetes is associated with an increased risk and progression of Alzheimer's (AD) and Parkinson's (PD) diseases. Conversely, diabetes may confer neuroprotection against amyotrophic lateral sclerosis (...
Neurodegenerative diseases are characterized by the progressive degeneration or death of neurons in the central or peripheral nervous system [...]....
Neurodegenerative diseases affect millions of people worldwide. The likelihood of developing a neurodegenerative disease rises dramatically as life expectancy increases. Although it has drawn signific...
Neurodegenerative diseases are among the most common diseases in older adults worldwide. Alzheimer's disease (AD) and Parkinson's disease (PD) are two of the most common neurodegenerative diseases, an...
Natural products are a promising source of novel lead structures that have long been used to treat various nervous system diseases....
This review collected literature on neurological diseases and natural products from 2012 to 2022, which were mainly searched through databases such as ScienceDirect, Springer, PubMed, SciFinder, China...
This review summarises the pathogenesis of degenerative neurological diseases, recent findings on natural products used in neurodegenerative diseases, and the molecular mechanisms underlying these eff...
Iron accumulation has been associated with the etiology and progression of multiple neurodegenerative diseases (NDDs). The exact role of iron in these diseases is not fully understood, but an iron-dep...